December 3, 2014 | The California Institute for Regenerative Medicine and Israel’s Center for R&D, MATIMOP, will cooperate to advance stem cell research and regenerative medicine. The agreement, which will be signed on December 5th, lays out the foundation for a potential Californian-Israeli stem cell research programs, with the goal of making it easier for researchers to obtain funding. At the signing of the agreement in San Francisco, MATIMOP will be represented Michel Hivert. MATIMOP is the executive agency of the Office of the Chief Scientist and is the national agency for research and development in Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments